Insider Transactions Reported by 14 Insiders of Processa Pharmaceuticals, Inc.

Symbol
PCSA on Nasdaq
Location
Vero Beach, FL

Insiders trading volume in the past year

Processa Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David Young Pres. Research & Development, Director $101K 01 Oct 2025
James H. Stanker Chief Financial Officer $61.6K 05 Apr 2024
Patrick Lin Chief Business - Strategy Off $59.9K +$34.7K +138% 01 Oct 2025
Sian Bigora Chief Development Officer $56.3K 01 Oct 2025
Michael Floyd Chief Operating Officer $51.6K 09 Feb 2023
Wendy Guy Chief Administrative Officer $49.9K 01 Oct 2025
VIRGIL THOMPSON Director $42.2K 27 Jun 2023
George Ng Chief Executive Officer, Director $31.7K 01 Oct 2025
Justin W. Yorke Director $11.2K +$9.89K +728% 01 Oct 2025
RUSSELL SKIBSTED Chief Financial Officer $5.88K 01 Oct 2025
Khalid Islam Director 31 Mar 2022
James Neal Director 01 Oct 2025
Khoso Baluch Director 01 Oct 2025
Geraldine Pannu Director 01 Oct 2025

Recent Insider Transactions by Companies or Individuals for Processa Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.